J - 医索

找到约 1905 条结果

Sparking the ConversationIntegrating ctDNA and Quality ofLife in Adjuvant Lung Cancer Care

医客学院 - 会议报告集

Neoadjuvant nivolumab plus chemotherapy vschemotherapy in patients with resectable NSCLC4-year update from CheckMate 816

医客学院 - 会议报告集

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

Managing Expectations WithAntibody-Drug Conjugates in Non-Small Cell Lung Cancer

医客学院 - 会议报告集

Health-related quality of life (HRQoL) results for adjuvant alectinib vs chemotherapy in patients with resected ALK NSCLC data from ALINA

医客学院 - 会议报告集

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas (DPM) Results of a prospective pilot study

医客学院 - 会议报告集

Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial

医客学院 - 会议报告集

A Phase ll Randomized Trial Evaluating ConsolidativeNivolumab in Locally Advanced Non-Small Cell LungCancer Post Neoadjuvant Nivolumab plus Chemotherapyand Concurrent chemoradiotherapy (CA209-7AL)

医客学院 - 会议报告集

Total neoadjuvant treatment with long-course radiotherapyversus concurrent chemoradiotherapy in local advanced rectalcancer with high risk factors (TNTCRT)A multicenter,randomized, open-label, phase

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

今日实时热搜